Future work could address this by investigating regional heterogeneity of the effects of insulin and IGF-1 signaling on brain myelination, as well as relating insulin action to myelination in animal models of obesity or diabetes. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.